Wikisage, the free encyclopedia of the second generation, is digital heritage
Bosentan: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
(png Bosentan Structural Formula V.1.svg.png) |
||
| Line 3: | Line 3: | ||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | {| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | ||
|colspan=2| <center> | |colspan=2| <center> | ||
[[File: | [[File:Bosentan Structural Formula V.1.svg.png|92px]] | ||
: [[wikipedia:bosentan|bosentan]] [https://www.whocc.no/atc_ddd_index/?code=C02KX01 C02KX01]</center> | : [[wikipedia:bosentan|bosentan]] [https://www.whocc.no/atc_ddd_index/?code=C02KX01 C02KX01]</center> | ||
|} | |} | ||
Latest revision as of 01:23, 10 May 2020
Anti-inflammatory that acts on endotelins. According to first line authors in ARDS. sildenafil appears as the best option in Eisenmenger syndrome.
ATC
|
Links
Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension [1]
